You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
8 November 2024 - Castle Biosciences Inc (Nasdaq: CSTL), a provider of diagnostic testing for skin cancers and other conditions, announced on Friday that it will present new data on its DecisionDx-Melanoma and MyPath Melanoma tests at the American So...
8 November 2024 - Bruker Corporation (Nasdaq: BRKR), a provider of scientific instruments and high value analytical and diagnostic solutions, on Friday announced EpicIF, an innovative fluorescence signal removal technology that significantly enhances...
8 November 2024 - IceCure Medical Ltd (Nasdaq: ICCM), a developer of minimally-invasive cryoablation technology, announced on Friday that it received a positive vote from the FDA's Medical Device Advisory Committee Panel, with 9 out of 14 paneli...
8 November 2024 - Biopharmaceutical company Dizal (SSE:688192) announced on Friday that it has submitted a New Drug Application (NDA) to the US FDA for sunvozertinib, targeting locally advanced or metastatic non-small cell lung cancer (NSCLC) with EG...
8 November 2024 - Harbour BioMed (HKEX: 02142), a global biopharmaceutical company, announced on Friday that it has submitted an Investigational New Drug (IND) application to the Centre for Drug Evaluation of China's National Medical Products Ad...
8 November 2024 - Biopharmaceutical company AstraZeneca PLC (LSE: AZN) (STO: AZN) (Nasdaq: AZN) announced on Friday that its drug Tezspire (tezepelumab), developed in partnership with Amgen, met both co-primary endpoints in the Phase III WAYPOINT tri...
8 November 2024 - Immunovia (NASDAQ STOCKHOLM: IMMNOV), a Sweden-based pancreatic cancer diagnostics company, announced on Thursday that it will present an update on its next-generation test at the annual meeting of the PRECEDE pancreatic cancer rese...